Australian Media Hails Chinese AI Innovation: Airdoc's Retinal Screening Tech Sparks Global Interest

On April 15, Australian television station 7NEWS reported on a new imaging detection technology. “A new method of fundus examination can help identify potential health risks. The entire process takes only one minute and can detect early signs of health risks,” the news report stated.

Screenshot-1 of the 7NEWS News Program Report

This news report primarily covers how a leading Australian insurance group has adopted world-class AI technology to conduct retinal screenings for its users, enabling the identification of ten potential health risks in just one minute.

It is reported that this retinal image analysis technology, developed by the Chinese AI company Airdoc and known as the “AI Retinal Health Risk Assessment System,” can detect early signs of health risks manifested as abnormalities in the retina, thereby playing a significant role in facilitating early detection and intervention of health risks.

Australian media outlet 7NEWS commented that the technology of “assessing health risks through retinal scans” “could revolutionize health management.”

Screenshot of Australian News Program 7NEWS Report - 2

7NEWS is Australia’s top-rated television station and the news division of the Seven Network. The broadcast sparked extensive discussion among international viewers online.

Netizen Michael believes, “It would be even better if the test could provide a range of health indicators.”

Netizens have discussed that the machines and technology for capturing retinal images, as well as the detection of health risks through retinal photography, have been around for many years. However, software utilizing artificial intelligence represents the most advanced technology, which is truly remarkable.

Currently, many insurance provider branches across Australia are utilizing this AI technology. Dr. Georgia Maloney stated that the AI technology has made her work more streamlined, efficient, and highly reliable. User Emma Ryan remarked, “It is bloodless and pain-free, offering exceptional safety and convenience.”

Airdoc’s products are not only deployed in Australia; its suite of solutions has achieved large-scale commercial adoption across dozens of insurance institutions, 150 health examination branches, over 400 hospitals, and 1,200 optometry centers worldwide, delivering non-invasive, safe, efficient, and precise health management services to tens of thousands of users daily.

Zhang Dalei, Founder and CEO of Airdoc, once stated, “In the foreseeable future, leveraging deep learning algorithms will not only enhance the image interpretation efficiency of senior physicians, allowing them to devote more energy to academic research and the management of complex and rare diseases, but also assist young doctors in performing rapid and accurate diagnoses and screenings, further supporting public health institutions and primary care facilities in conducting large-scale disease screening.”

With continuous breakthroughs in the application of artificial intelligence in medicine, and increasing attention and coverage from domestic and international media, it is reasonable to believe that this AI-based retinal health risk assessment technology will soon become widely accessible to the general public around the world.